1. Accuracy of intestinal permeability in predicting the development of complications in patients with liver cirrhosis. (10th February 2016) Authors: Ponziani, F.R.; Valenza, V.; Annicchiarico, B.E.; Siciliano, M.; Pompili, M.; Gasbarrini, A. Journal: Digestive and liver disease Issue: Volume 48(2016)Supplement 1 Page Start: e34 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Clinical impact of comorbidities in an Italian NAFLD cohort. (February 2019) Authors: Miele, L.; Liguori, A.; Marrone, G.; Ponziani, F.R.; Tortora, A.; Abbate, V.; Ainora, M.E.; Rinninella, E.; De Matthaeis, N.; Pizzolante, F.; Biolato, M.; Zocco, M.A.; Riccardi, L.; Mele, M.C.; Siciliano, M.; Addolorato, G.; Pompili, M.; Rapaccini, G.L.; Gasbarrini, A.; Grieco, A. Journal: Digestive and liver disease Issue: Volume 51(2019)Supplement 1 Page Start: e32 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Daclatasvir/sofosbuvir and ribavirin 800 mg flat dose is highly efficacy and safe in genotype 3 compensated and decompensated cirrhotic patients: The CLEO experience. Issue 1 (16th February 2017) Authors: Pellicelli, A.; Messina, V.; Tarquini, P.; Pace Palitti, V.; Ceccherini Silberstein, F.; Pompili, M.; Gulminetti, R.; Cerasari, G.; D'Ambrosio, C.; Villani, R.; Fondacaro, L.; Dell'isola, S.; Babudieri, S.; Iovinella, V.; Di Candilo, F.; Chiesara, F.; Di Maio, V.C.; Ponziani, F.R.; Sacco, R.; Izz... Journal: Digestive and liver disease Issue: Volume 49:Issue 1(2017)Supplement Page Start: e64 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Effectiveness of HCV antiviral treatment in patients with cirrhosis or advanced fibrosis and end-stage kidney disease on dialysis. Issue 1 (16th February 2017) Authors: Ponziani, F.R.; Siciliano, M.; Lionetti, R.; Pasquazzi, C.; Gianserra, L.; Lambiase, L.; D'Offizi, G.; Gasbarrini, A.; Pompili, M. Journal: Digestive and liver disease Issue: Volume 49:Issue 1(2017)Supplement Page Start: e24 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. First steps towards understanding the dynamic evolution of gut microbiota in different stages of liver disease. (15th February 2015) Authors: Ponziani, F.R.; Pecere, S.; Sterbini, F. Paroni; Petito, V.; Siciliano, M.; Di Rienzo, T.; Palladini, A.; Zambrano, D.; Franceschi, F.; Gaetani, E.; Scaldaferri, F.; Masucci, L.; Sanguinetti, M.; Gasbarrini, A. Journal: Digestive and liver disease Issue: Volume 47(2015)Supplement 1 Page Start: e53 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. FVIII/PC and ADAMTS13/VWF ratio to predict liver-related events and mortality in patients with ACLD. (March 2023) Authors: Giuli, L.; Pallozzi, M.; Santopaolo, F.; Gasbarrini, A.; De Cristofaro, R.; Pompili, M.; Ponziani, F.R. Journal: Digestive and liver disease Issue: Volume 55(2023)Supplement 1 Page Start: S41 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Hepatocellular liver injury in hospitalized patients affected by COVID-19: Different factors at different time points. (March 2021) Authors: Leo, M.; Galante, A.; Pagnamenta, A.; Ponziani, F.R.; Gasbarrini, A.; De Gottardi, A. Journal: Digestive and liver disease Issue: Volume 53:(2021)Supplement 1 Page Start: S21 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Hepatocellular liver injury in hospitalized patients affected by COVID-19: Presence of different risk factors at different time points. Issue 5 (May 2022) Authors: Leo, M.; Galante, A.; Pagnamenta, A.; Ruinelli, L.; Ponziani, F.R.; Gasbarrini, A.; De Gottardi, A. Journal: Digestive and liver disease Issue: Volume 54:Issue 5(2022) Page Start: 565 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Lack of reduction of serum alphafetoprotein during treatment with direct antiviral agents predicts hepatocellular carcinoma development in a large cohort of patients with HCV-related cirrhosis. Issue 1 (February 2018) Authors: Masetti, C.; Lionetti, R.; Lupo, M.; Siciliano, M.; Giannelli, V.; Ponziani, F.R.; Teti, E.; Dell'Unto, C.; Francioso, S.; Brega, A.; Montalbano, M.; Visco-Comandini, U.; Taibi, C.; Galati, G.; Gentilucci, U. Vespasiani; Picardi, A.; Andreoni, M.; Pompili, M.; Pellicelli, A.M.; D'Offizi, G. Journal: Digestive and liver disease Issue: Volume 50:Issue 1(2018)Supplement Page Start: 4 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Long-term results from the Italian real-world experience on obeticholic acid treatment in primary biliary cholangitis: The RECAPITULATE study. (March 2023) Authors: Terracciani, F.; De Vincentis, A.; D'Amato, D.; Invernizzi, P.; Morgando, A.; Vanni, E.; Viganò, M.; Alvaro, D.; Venere, R.; Lleo, A.; Colapietro, F.; Degasperi, E.; Viganò, R.; Giannini, E.G.; Labanca, S.; Feletti, V.; Mussetto, A.; Cozzolongo, R.; Losito, F.; Pompili, M. Journal: Digestive and liver disease Issue: Volume 55(2023)Supplement 1 Page Start: S44 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗